ABVC BioPharma's subsidiary, AiBtl BioPharma, has signed a strategic agreement to acquire agricultural land in Taiwan for cultivating key ingredients for their botanical drug candidates. This move aims to reduce sourcing risk and support large-scale production of botanical compounds.